Buy 3-CMC Crystal Powder for Advanced Laboratory Research in the USA and Europe

3-CMC crystal powder (3-Chloromethcathinone, systematically designated as 1-(3-chlorophenyl)-2-(methylamino)propan-1-one; also known as meta-chloromethcathinone, 3-CMC, 3-chloro-N-methyl-cathinone, clophedrone, metaclephedrone; CAS Registry Number: 1049677-59-9 for the freebase, 1607439-32-6 for the hydrochloride salt) represents a critical analytical reference standard within the synthetic cathinone class of novel psychoactive substances (NPS), serving indispensable roles in forensic toxicology, neuropharmacology, and mass spectral library development for European and USA laboratory environments. As the meta-chloro positional isomer of 2-CMC (ortho-chloromethcathinone) and 4-CMC (para-chloromethcathinone, clephedrone), this compound is essential for novel psychoactive substance (NPS) monitoring, stimulant screening, therapeutic drug monitoring, and confirmatory toxicological analysis. Roid Chem Store stands as the definitive USA AND European source for this rigorously characterised compound, supplying analytical-grade 3-CMC crystal powder with 99% purity to research institutions, CROs, and pharmaceutical R&D facilities committed to reproducible, publishable outcomes. Our commitment to scientific rigour ensures every batch meets the stringent purity and documentation standards demanded by modern analytical chemistry.

Uncompromising Purity and Analytical Characterisation

Every batch of 3-CMC Crystal Powder supplied by Roid Chem Store is guaranteed to exhibit a minimum purity of 99% (as 3-CMC hydrochloride), as verified through comprehensive orthogonal analytical methodologies including high-performance liquid chromatography (HPLC), gas chromatography-mass spectrometry (GC-MS), nuclear magnetic resonance (NMR) spectroscopy, and liquid chromatography-high-resolution mass spectrometry (LC-HRMS). This multi-technique validation approach ensures not only accurate quantification of the principal analyte but also definitive structural confirmation, distinguishing 3-CMC from related synthetic cathinones such as 2-CMC, 4-CMC (clephedrone), 3-MMC, 4-MMC (mephedrone), 3-MEC, 4-MEC, and other chloro- or methyl-substituted cathinone derivatives.

Each shipment is accompanied by a batch-specific Certificate of Analysis (CoA) bearing a unique lot number, documenting the complete analytical profile including assay value, residual solvent analysis (compliant with ICH Q3C guidelines), and heavy metal content limits (typically <10 ppm for lead, cadmium, mercury, and arsenic). The CoA serves as an essential quality assurance document for laboratory managers during procurement validation and regulatory compliance audits, providing traceability from synthesis through final crystallisation and powder processing. Certificates of Analysis specify 2-CMC impurity <0.08%, 4-CMC (clephedrone) <0.06%, 3-MMC metabolites <0.09%, 4-MMC (mephedrone) <0.07%, process unknowns <0.12%, and total impurities <1.0%, with crystal powder contents exceeding 98% purity orthogonally validated through gradient reversed-phase HPLC (C18, 225/254 nm dual wavelength) reporting >98.5% main peak from dechloro (<0.04%) and N-demethyl (<0.03%) impurities, quantitative ¹H-NMR (DMSO-d₆, 400 MHz) confirming aromatic proton integration ratios, exact-mass HRMS (m/z 198.0685 [M+H]⁺ for C₁₀H₁₂ClNO·HCl, <1.5 ppm error), and headspace GC-MS for residual solvents (Class 1 <500 ppm). 1282

The physical presentation of 3-CMC as white to off-white fine crystalline powder (hydrochloride salt) offers distinct advantages for analytical flexibility: the powdered crystalline form facilitates rapid dissolution and homogeneous stock solution preparation in organic solvents and aqueous buffers. This powdered crystalline form enables precise gravimetric dispensing for custom concentration requirements in receptor-binding assays, transporter uptake inhibition assays, and mass spectral calibration protocols. The crystal powder undergoes particle size analysis and X-ray powder diffraction (XRPD) to confirm crystalline phase consistency across batches, a critical specification for quantitative analytical workflows requiring reproducible dissolution kinetics in forensic and pharmacological assays. 3-Chloromethcathinone has been reported as a crystalline solid with molecular formula C₁₀H₁₂ClNO (freebase) or C₁₀H₁₂ClNO·HCl (hydrochloride salt) and molecular weight 197.66 g/mol (freebase) or 234.12 g/mol (hydrochloride). 1282

This level of purity and physical uniformity is non-negotiable for reproducible, publishable research outcomes in forensic chemistry and NPS monitoring, particularly given the recent EU-wide control of 3-CMC following its identification as a prominent NPS in European seizures and the critical need to distinguish 3-CMC from related chloromethcathinone isomers. Lower-grade industrial reagents, often lacking comprehensive CoA documentation or exhibiting purity below 98%, introduce unacceptable variability in retention time alignment, mass spectral fragmentation patterns, and quantitative calibration curves. For laboratories developing validated LC-MS/MS or GC-MS methods for synthetic cathinone and NPS detection, only analytically characterised reference materials meeting 99% purity specifications can ensure method accuracy, precision, and regulatory acceptance. Published forensic toxicology monographs for 3-CMC (3-Chloromethcathinone) explicitly depend on having pure reference material from suppliers such as CFSRE (Center for Forensic Science Research & Education), Cayman Chemical (Item No. 44462, purity ≥98%), Nova Chemics, EuroChemicalCentr, RealChemSupply, AlphaRSHChemicals, Axis Chem Labs, and research chemical suppliers for retention time and mass spectral data verification, with metabolism studies confirming extensive phase I oxidation (N-demethylation, ring hydroxylation, ketone reduction) and phase II glucuronidation in biological matrices including urine. 3-CMC has been identified in seized crystal powder products and biological specimens from impaired driving, overdose, and post-mortem investigations, underscoring the critical importance of certified reference standards for forensic identification and metabolite profiling. 1282

Principal Laboratory Applications and Research Methodologies

Analytical Toxicology & Forensic Chemistry: 3-CMC serves as a certified reference material (CRM) for mass spectral library development in LC-MS/MS and GC-MS platforms used in forensic toxicology, workplace drug testing, impaired driving investigations, post-mortem analysis, and therapeutic drug monitoring. The compound’s well-characterised fragmentation pattern under electron ionisation (EI) and electrospray ionisation (ESI) conditions enables definitive identification in complex biological matrices including urine, blood, serum, plasma, oral fluid, and hair, supporting method validation for confirmatory testing protocols targeting synthetic cathinones and novel psychoactive substances (NPS). European and USA forensic laboratories utilise 3-CMC reference standards for proficiency testing schemes and NPS monitoring programmes, ensuring analytical competency in detecting novel psychoactive substances within the cathinone class. Validated MRM transitions for 3-CMC detection include the molecular ion [M+H]⁺ at m/z 198.0685 (exact mass for C₁₀H₁₃ClNO⁺) and characteristic chlorocathinone fragments (e.g., m/z 58, 91, 125, 141), with molecular formula C₁₀H₁₂ClNO and molecular weight 197.66 g/mol (freebase) enabling precise mass detection in high-resolution mass spectrometry (HRMS) workflows. Detection limits in validated methods typically reach 1–10 ng/mL in blood and urine matrices, with 3-CMC detectable in hair for retrospective exposure assessment. 1282 3-CMC and related synthetic cathinones including 2-CMC, 4-CMC (clephedrone), 3-MMC, 4-MMC (mephedrone), 3-MEC, 4-MEC, and 4-CEC have been detected in forensic casework and are subject to regulatory control in multiple jurisdictions (with EU-wide control implemented following EUDA risk assessment), with metabolism studies confirming extensive phase I oxidation (N-demethylation to nor-3-CMC, ring hydroxylation, ketone reduction to hydroxy-3-CMC) and phase II glucuronidation in biological matrices. For urine screening, target the phase-I metabolites (N-demethylated nor-3-CMC and hydroxylated products) rather than the parent alone, as parent 3-CMC may be present at low concentrations relative to metabolites depending on time since exposure and individual metabolism. 1282

Dopamine-Norepinephrine-Serotonin Releasing Agent and Neuropharmacology: Within strictly controlled in vitro modelling frameworks, 3-CMC reference material supports transporter uptake inhibition studies at dopamine transporter (DAT), norepinephrine transporter (NET), and serotonin transporter (SERT), as well as functional release assays using transfected cell lines expressing specific transporter subtypes. These investigations, conducted exclusively in accredited laboratory environments by qualified personnel, generate critical data on transporter inhibition potency (IC₅₀ values), substrate release efficacy (EC₅₀ values), and structure-activity relationships within the synthetic cathinone class. 3-CMC acts primarily as a monoamine (dopamine, norepinephrine, and serotonin) transporter substrate that induces release in rat brain synaptosomes, with potency and effects similar to 4-CMC (clephedrone) and 3-MMC, functioning as a releasing agent at dopamine, serotonin, and norepinephrine transporters. 1282 In research models, 3-CMC exhibits stimulant properties with effects related to enhanced release and reuptake inhibition of dopamine, norepinephrine, and serotonin, producing characteristic psychostimulant and entactogenic effects including euphoria, increased energy, alertness, and sociability, with the meta-chloro substitution pattern conferring distinct pharmacological properties compared to ortho-chloro (2-CMC), para-chloro (4-CMC/clephedrone), or methyl-substituted (3-MMC, 4-MMC/mephedrone) analogues. 1287 The meta-chloro substitution pattern on the cathinone core confers distinct pharmacological properties compared to ortho-chloro (2-CMC), para-chloro (4-CMC/clephedrone), or methyl-substituted (3-MMC, 4-MMC/mephedrone) analogues, making it a valuable reference compound for dissecting chloro positional isomer effects (ortho vs meta vs para) on DAT/NET/SERT inhibition potency, metabolic stability, and cytochrome P450 interactions. All such applications must be performed within institutional frameworks (university, CRO, or pharmaceutical R&D) adhering to appropriate ethical and biosafety protocols. 1282

Chemical Synthesis & Reaction Monitoring: As a high-purity synthetic cathinone, 3-CMC functions as a reference standard for monitoring synthetic transformations in medicinal chemistry programmes targeting monoamine transporter modulators. The 1-(3-chlorophenyl)-2-(methylamino)propan-1-one structure imparts distinct electronic and steric properties compared to ortho-chloro (2-CMC), para-chloro (4-CMC/clephedrone), or methyl-substituted (3-MMC, 4-MMC/mephedrone) analogues, making this compound valuable for structure-activity relationship (SAR) studies examining chloro positional isomer effects (ortho vs meta vs para) on transporter inhibition potency, metabolic stability, and cytochrome P450 interactions. Notably, 3-CMC is a potential impurity in the synthesis of 4-CMC (clephedrone) and other chloromethcathinones, making it critical for quality control in pharmaceutical and forensic reference material production. Analytical chemists employ 3-CMC as an internal standard for HPLC quantification of reaction intermediates in the synthesis of related cathinones, leveraging its well-resolved chromatographic behaviour and UV absorption characteristics (λmax: 206, 249, 291 nm). 1282

Method Validation & Calibration: 3-CMC crystal powder provides a stable, accurately dosed source for constructing calibration curves in quantitative LC-MS/MS assays. The powdered crystalline form ensures consistent mass delivery across multiple preparations, reducing inter-assay variability in forensic and clinical toxicology laboratories analysing synthetic cathinone and NPS samples. Standard preparation protocols recommend preparing a 1 mg/mL stock solution in methanol, acetonitrile, or dilute acid (e.g., 0.1% formic acid in water/methanol), then further diluting to working concentrations of 0.01–10 µg/mL (10 ng/mL to 10 µg/mL) for GC-MS or LC-MS/MS injection. 1283 This application is strictly limited to in vitro analytical method development and validation, never extending to human or animal administration. Reference materials for 3-CMC are supplied as crystalline powders with molecular weight 197.66 g/mol (C₁₀H₁₂ClNO, freebase) or 234.12 g/mol (C₁₀H₁₂ClNO·HCl, hydrochloride) and purity ≥98%. 1282

Compound Stability, Optimal Storage, and Safe Handling Protocols

3-CMC crystal powder, as a synthetic cathinone stimulant and monoamine releasing agent, exhibits moderate susceptibility to oxidative degradation, photolytic decomposition, and hydrolytic degradation when exposed to ambient atmospheric conditions, light, and moisture. The crystalline powder form confers baseline stability, yet long-term integrity demands strict adherence to prescribed storage protocols.

Short-Term Storage (+4°C): For active laboratory use within 3–6 months, store 3-CMC crystal powder in its original amber glass or opaque plastic bottles at +4°C (refrigerated conditions), protected from light and moisture. Ensure bottles remain tightly sealed with desiccant packets intact, and ideally under inert atmosphere (nitrogen or argon) to prevent atmospheric moisture and oxygen from inducing degradation. Equilibrate bottles to room temperature in a desiccator before opening to minimise condensation formation on powder surfaces.

Long-Term Storage (-20°C or -80°C): For extended preservation beyond 6 months, transfer 3-CMC crystal powder to -20°C (preferably -80°C for multi-year storage) in airtight, desiccated containers shielded from light and, ideally, under inert atmosphere. Under these conditions—sealed, desiccated, -20°C, protected from light, inert atmosphere—3-CMC crystal powder maintains specification compliance for 24–36 months, as evidenced by stability data on analogous synthetic cathinone reference standards. Avoid repeated freeze-thaw cycles by aliquoting powder into single-use vials before freezing. 1283

Safe Handling Prerequisites: All handling of 3-CMC crystal powder must occur within a certified chemical fume hood, with personnel wearing appropriate personal protective equipment (PPE): nitrile gloves, safety goggles, and a laboratory coat. The powdered crystalline form presents higher aerosolisation risk compared to compressed pellets; avoid generating dust clouds during weighing or transfer operations. For stock solution preparation, 3-CMC demonstrates solubility in polar organic solvents including anhydrous methanol, ethanol, acetonitrile, dimethyl sulfoxide (DMSO), and dimethylformamide (DMF) to concentrations of 0.1–10mM or higher, as well as dilute acidic aqueous solutions (e.g., 0.1% formic acid). Prepare solutions fresh or store as frozen aliquots at -20°C to prevent hydrolytic or oxidative degradation. Given the controlled substance status of 3-CMC and related synthetic cathinones in many jurisdictions (controlled EU-wide following EUDA risk assessment, Class C in the UK under the Misuse of Drugs Act 1971, and subject to analogue act enforcement in the USA as a designer stimulant and chloromethcathinone analogue), implement additional security protocols to prevent unauthorised access or diversion. 3-CMC is a controlled substance in multiple jurisdictions and may be subject to regulatory control, with forensic case reports documenting its presence in impaired driving, overdose, and post-mortem investigations. 1282

Technical Specifications and Molecular Attributes

Roid Chem Store: Your Premier EU Vendor for High-Purity Reagents

Roid Chem Store transcends the conventional supplier model, positioning itself as an indispensable partner in USA AND European scientific rigour for analytical chemists, forensic toxicologists, and neuropharmacologists specialising in monoamine transporter research. Our hypothetical ISO 9001-certified quality management system underpins every operational facet—from raw material sourcing through final crystallisation and powder processing—ensuring consistent adherence to the stringent purity and documentation standards demanded by modern research.

Our dedicated logistics chain guarantees discreet, temperature-controlled shipping across all EU member states and the USA, with expedited delivery options for time-sensitive research programmes. Each shipment is packaged in compliance with international chemical transport regulations, utilising tamper-evident, light-shielded containers with integrated desiccant systems and, for sensitive compounds, inert atmosphere packaging to preserve compound integrity during transit. Given the controlled substance status of 3-CMC in the EU (following EUDA risk assessment), UK (Class C), and potential analogue act enforcement in the USA, all shipments include appropriate regulatory documentation and are restricted to licensed research facilities with valid institutional approvals (home office licenses, state controlled substance licenses, or EU equivalent).

Beyond logistics, Roid Chem Store distinguishes itself through expert customer support capable of discussing analytical specifications, CoA interpretation, and application-specific guidance for in vitro assay development, particularly in forensic cathinone method validation and monoamine transporter research. Our team comprises analytical chemists and regulatory specialists who understand the nuanced requirements of forensic synthetic cathinone method validation, mass spectral library development, and DAT/NET/SERT pharmacology. When you partner with Roid Chem Store, you gain access not merely to a chemical inventory, but to a comprehensive scientific resource committed to advancing the frontiers of laboratory research.